Alnylam Pharmaceuticals will employ more than 100 people to launch its “gene-silencing” therapies across Europe Getty ImagesA multibillion-dollar American healthcare company is to open its European headquarters in the UK in a vote of confidence for Britain’s status as an international trade centre. Alnylam Pharmaceuticals will plant its flag in Theresa May’s constituency in Maidenhead, Berkshire, employing more than 100 people to launch its new “gene-silencing” therapies across Europe. The deal is good news for the prime minister amid uncertainty over the future of Britain’s trade position with the US. President Obama has warned Mrs May that the UK will be at the back of the queue when it comes to negotiating a new deal.

Source: The Times September 20, 2016 23:05 UTC